Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies

American Journal of Transplantation

Volumn 10, Issue 9, 2010, Pages 2051-2060

  Canaud, G ^a,b,c   Bienaime F ^a,c,d   Noel L H ^a,d   Royal, V ^a,d   Alyanakian, M A ^a,d   Dautzenberg, M D ^a,d   Rabant, M ^a,b   Posson, J ^b   Thervet, E ^a,b   Anglicheau, D ^a,b   Kreis, H ^a,b   Martinez, F ^a,b   Legendre, C ^a,b   Zuber, J ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Centre de Recherche Croissance et Signalisation   (France)

^c INSERM   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Anticardiolipin antibodies; Banff lesions; glomerular filtration rate; thrombosis and kidney transplantation; transplant vascular sclerosis; vascular disease

Indexed keywords

AZATHIOPRINE; HEPARIN; LUPUS ANTICOAGULANT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHOLIPID ANTIBODY; TACROLIMUS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ANTIPHOSPHOLIPID SYNDROME ASSOCIATED NEPHROPATHY; ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL RATE; THROMBOSIS; TREATMENT OUTCOME; VASCULAR LESION; VEIN THROMBOSIS;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BIOPSY; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VASCULAR DISEASES; VENOUS THROMBOSIS;

EID: 77956165039     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03233.x     Document Type: Article

References (31)

1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002 346 : 752 763.
2. Galli M, Barbui T. Antiphospholipid syndrome: Clinical and diagnostic utility of laboratory tests. Semin Thromb Hemost 2005 31 : 17 24.
3. Nojima J, Iwatani Y, Suehisa E, Kuratsune H, Kanakura Y. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Haematologica 2006 91 : 699 702.
4. Nochy D, Daugas E, Droz D et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 1999 10 : 507 518.
5. Daugas E, Nochy D, Huong DL et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 2002 13 : 42 52.
6. Leaker B, McGregor A, Griffiths M, Snaith M, Neild GH, Isenberg D. Insidious loss of renal function in patients with anticardiolipin antibodies and absence of overt nephritis. Br J Rheumatol 1991 30 : 422 425.
7. Moroni G, Ventura D, Riva P et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis 2004 43 : 28 36.
8. Harada M, Fujisawa Y, Sakisaka S et al. High prevalence of anticardiolipin antibodies in hepatitis C virus infection: Lack of effects on thrombocytopenia and thrombotic complications. J Gastroenterol 2000 35 : 272 277.
9. Dalekos GN, Zachou K, Liaskos C. The antiphospholipid syndrome and infection. Curr Rheumatol Rep 2001 3 : 277 285.
10. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 2000 15 : 145 151.
11. Stone JH, Amend WJ, Criswell LA. Antiphospholipid antibody syndrome in renal transplantation: Occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. Am J Kidney Dis 1999 34 : 1040 1047.
12. Vaidya S, Gugliuzza K, Daller JA. Efficacy of anticoagulation therapy in end-stage renal disease patients with antiphospholipid antibody syndrome. Transplantation 2004 77 : 1046 1049.
13. Ducloux D, Pellet E, Fournier V et al. Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients. Transplantation 1999 67 : 90 93.
14. Wagenknecht DR, Becker DG, LeFor WM, McIntyre JA. Antiphospholipid antibodies are a risk factor for early renal allograft failure. Transplantation 1999 68 : 241 246.
15. Forman JP, Lin J, Pascual M, Denton MD, Tolkoff-Rubin N. Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant 2004 4 : 1786 1791.
16. Viard JP, Amoura Z, Bach JF. Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992 93 : 181 186.
17. Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 4 : 295 306.
18. Pengo V, Tripodi A, Reber G et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009 7 : 1737 1740.
19. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008 8 : 753 760.
20. Anglicheau D, Loupy A, Suberbielle C et al. Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: A pilot study. Am J Transplant 2007 7 : 1185 1192.
21. Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 2009 20 : 2305 2313.
22. Erkan D, Leibowitz E, Berman J, Lockshin MD. Perioperative medical management of antiphospholipid syndrome: Hospital for special surgery experience, review of literature, and recommendations. J Rheumatol 2002 29 : 843 849.
23. Marcen R, Pascual J, Quereda C et al. Lupus anticoagulant and thrombosis of kidney allograft vessels. Transplant Proc 1990 22 : 1396 1398.
24. Asherson RA, Cervera R, Piette JC et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine 1998 77 : 195 207.
25. Manns BJ, Burgess ED, Parsons HG, Schaefer JP, Hyndman ME, Scott-Douglas NW. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney Int 1999 55 : 315 320.
26. Garcia-Martin F, De Arriba G, Carrascosa T et al. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol Dial Transplant 1991 6 : 543 547.
27. Hill GS, Nochy D, Loupy A. Accelerated arteriosclerosis: A form of transplant arteriopathy. Curr Opin Organ Transplant 15 : 11 15.
28. Ahn ER, Lander G, Bidot CJ, Jy W, Ahn YS. Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy. Am J Hematol 2005 78 : 127 129.
29. Rubenstein E, Arkfeld DG, Metyas S, Shinada S, Ehresmann S, Liebman HA. Rituximab treatment for resistant antiphospholipid syndrome. J Rheumatol 2006 33 : 355 357.
30. Lonze BE, Singer AL, Montgomery RA. Eculizumab and renal transplantation in a patient with CAPS. N Engl J Med 362 : 1744 1745.
31. Girardi G, Redecha P, Salmon JE. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004 10 : 1222 1226.